Tech Company Financing Transactions
AstraZeneca Funding Round
AstraZeneca closed a $3.4 million funding round on 2/11/2026. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/11/2026
Transaction Type
Debt
Amount
$3,400,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
9 Västra Mälarehamnen
London, 151 36
Sweden
London, 151 36
Sweden
Phone
Website
Email Address
Not Recorded
Overview
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Leif Johansson
Chief Executive Officer
Pascal Soriot
Chief Financial Officer
Marc Dunoyer
Executive Vice President
Ruud Dobber
Executive Vice President
Iskra Reic
Executive Vice President
Leon Wang
VP - Bus. Development
David Fredrickson
VP - Bus. Development
Menelas Pangalos
VP - Human Resources
Fiona Cicconi
VP - Operations
Pam Cheng
Browse more venture capital transactions:
Prev: 2/10/2026: Trener Robotics venture capital transaction
Next: 2/11/2026: Complyance venture capital transaction
Share this article
Where The Data Comes From
We document funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs